Alex Watt

1 month ago | pharmaceutical-technology.com | Alex Watt

A key trend seen this year is the simplification of basket sizes, as countries streamline and simplify. Higher-income markets are less likely to apply IRP to generic medicines. Credit: MOLPIX via Shutterstock. International reference pricing (IRP), also known as external reference pricing (ERP), is one element commonly used when setting the price of medicines in different markets.

2 months ago | businessandamerica.com | Alex Watt

Drug manufacturers faced a variety of hurdles in 2024. Healthcare system reforms, preparation for the EU joint clinical assessments (JCAs) that went live at the end of January 2025, and drug shortages, alongside governments’ focus on cost containment, are only a few of these challenges. In this review, GlobalData considers the products that were both approved and priced in 2024 and the factors that influenced their launch strategy.

2 months ago | pharmaceutical-technology.com | Alex Watt

To understand the key launch trends in 2024, GlobalData reviewed a sample of innovative drugs that were both approved and priced in 2024. In GlobalData’s analysis of 2024 launch trends for selected drugs, each market’s health technology assessments (HTAs) were also considered. Image: LeoWolfert via Shutterstock. Drug manufacturers faced a variety of hurdles in 2024.

Nov 25, 2024 | pharmaceutical-technology.com | Alex Watt

Most drug shortages apply to the same active ingredient across multiple markets while generics see the greatest difficulties. The increasing number of drug shortages, especially in 2023 and 2024, has become a driver for pricing and reimbursement policy changes. Credit: Alan Sau via Shutterstock. Since 2023, the pharmaceutical industry operating in Europe has faced an unprecedented challenge related to drug shortages.

Nov 25, 2024 | finance.yahoo.com | Alex Watt

Exploring drug shortages in european markets: the causes, analysis, and response The increasing number of drug shortages · Pharmaceutical Technology Mon, November 25, 2024 at 3:07 AM PST 5 min read In This Article: Since 2023, the pharmaceutical industry operating in Europe has faced an unprecedented challenge related to drug shortages. Previously, shortages were dictated by production capacity and changing market conditions.